Manuel Sánchez‐Chapado

2.4k total citations
94 papers, 1.7k citations indexed

About

Manuel Sánchez‐Chapado is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Manuel Sánchez‐Chapado has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 32 papers in Surgery and 28 papers in Molecular Biology. Recurrent topics in Manuel Sánchez‐Chapado's work include Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (23 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Manuel Sánchez‐Chapado is often cited by papers focused on Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (23 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Manuel Sánchez‐Chapado collaborates with scholars based in Spain, United States and United Kingdom. Manuel Sánchez‐Chapado's co-authors include J.C. Angulo, Marı́a J. Carmena, Benito Fraile, Mar Royuela, M. Isabel Arenas, Ricardo Paniagua, Juan Carlos Prieto, Ana M. Bajo, Gabriel Olmedilla and José Escribano and has published in prestigious journals such as International Journal of Molecular Sciences, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Manuel Sánchez‐Chapado

93 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Sánchez‐Chapado Spain 24 646 560 388 264 238 94 1.7k
P D Abel United Kingdom 22 416 0.6× 598 1.1× 503 1.3× 261 1.0× 189 0.8× 54 1.7k
Hirofumi Koga Japan 24 589 0.9× 569 1.0× 553 1.4× 379 1.4× 133 0.6× 85 2.1k
Markus Müller Germany 24 407 0.6× 1.0k 1.8× 580 1.5× 211 0.8× 338 1.4× 51 1.8k
Janice G. Dodd Canada 20 664 1.0× 733 1.3× 225 0.6× 271 1.0× 197 0.8× 33 1.6k
Shusuke Akamatsu Japan 21 884 1.4× 692 1.2× 154 0.4× 279 1.1× 573 2.4× 156 1.8k
Hitoshi Niikura Japan 30 288 0.4× 673 1.2× 432 1.1× 553 2.1× 233 1.0× 97 2.5k
Paola Muzi Italy 23 467 0.7× 661 1.2× 124 0.3× 405 1.5× 254 1.1× 52 1.5k
Yongmei Chen United States 26 1.5k 2.3× 757 1.4× 208 0.5× 348 1.3× 566 2.4× 96 2.4k
S. Bruce Malkowicz United States 21 349 0.5× 381 0.7× 264 0.7× 135 0.5× 115 0.5× 59 1.2k
Vonn Walter United States 24 387 0.6× 1.0k 1.8× 420 1.1× 461 1.7× 399 1.7× 98 2.0k

Countries citing papers authored by Manuel Sánchez‐Chapado

Since Specialization
Citations

This map shows the geographic impact of Manuel Sánchez‐Chapado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Sánchez‐Chapado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Sánchez‐Chapado more than expected).

Fields of papers citing papers by Manuel Sánchez‐Chapado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Sánchez‐Chapado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Sánchez‐Chapado. The network helps show where Manuel Sánchez‐Chapado may publish in the future.

Co-authorship network of co-authors of Manuel Sánchez‐Chapado

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Sánchez‐Chapado. A scholar is included among the top collaborators of Manuel Sánchez‐Chapado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Sánchez‐Chapado. Manuel Sánchez‐Chapado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bajo, Ana M., et al.. (2018). Does [-2]Pro-Prostate Specific Antigen Meet the Criteria to Justify Its Inclusion in the Clinical Decision-Making Process?. Urologia Internationalis. 100(2). 146–154. 1 indexed citations
2.
Angulo, J.C., C. Redondo, Manuel Sánchez‐Chapado, et al.. (2016). Survival predictors in patients with prostate adenocarcinoma with hormonal blockade. Pathology - Research and Practice. 212(10). 899–903. 3 indexed citations
3.
Sánchez‐Chapado, Manuel, et al.. (2014). Asociación entre síndrome metabólico y cáncer de próstata: efecto sobre su agresividad y progresión. Actas Urológicas Españolas. 39(3). 154–160. 10 indexed citations
4.
Sánchez‐Chapado, Manuel, et al.. (2014). Evolución de las características del paciente candidato a prostatectomía radical y de los resultados obtenidos con la técnica. Actas Urológicas Españolas. 39(2). 78–84. 3 indexed citations
5.
Fernández‐Martínez, Ana B., et al.. (2014). VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells. Cellular Signalling. 27(2). 236–244. 14 indexed citations
6.
García-Tello, A., J.C. Angulo, Javier Rodríguez‐Ubreva, et al.. (2014). Anatomía de la próstata en ratones motheaten viable (mev) con mutaciones en el gen de la proteína tirosina fosfatasa SHP-1. Actas Urológicas Españolas. 38(7). 438–444. 2 indexed citations
7.
Arenas, M. Isabel, Laura Muñoz‐Moreno, Ana M. Bajo, et al.. (2013). Antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice. Cancer Letters. 336(1). 196–203. 10 indexed citations
8.
Fata, F. Ramón de, Antonio Ferruelo, Guillermo Andrés, et al.. (2013). El papel de la metaloproteinasa de la matriz MMP-9 y del inhibidor tisular de metaloproteinasa TIMP-2 como marcadores séricos de cáncer vesical. Actas Urológicas Españolas. 37(8). 480–488. 11 indexed citations
9.
Andrés, Guillermo, et al.. (2013). El estudio de la metilación del ADN en el cáncer urológico: presente y futuro. Actas Urológicas Españolas. 37(6). 368–375. 13 indexed citations
10.
Fernández‐Martínez, Ana B., Ana M. Bajo, Manuel Sánchez‐Chapado, et al.. (2012). Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(10). 1676–1685. 26 indexed citations
11.
Sotomayor, Sandra, Laura Muñoz‐Moreno, Marı́a J. Carmena, et al.. (2010). Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN‐215) and a bombesin antagonist (RC‐3095). International Journal of Cancer. 127(8). 1813–1822. 21 indexed citations
12.
Fernández‐Martínez, Ana B., Ana M. Bajo, Manuel Sánchez‐Chapado, Juan Carlos Prieto, & Marı́a J. Carmena. (2009). Vasoactive intestinal peptide behaves as a pro‐metastatic factor in human prostate cancer cells. The Prostate. 69(7). 774–786. 27 indexed citations
13.
Bajo, Ana M., Juan Carlos Prieto, Manuel Sánchez‐Chapado, et al.. (2007). Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone. International Journal of Oncology. 31(5). 1223–30. 17 indexed citations
14.
Wirth, Manfred P., C. Tyrrell, K.P.J. Delaere, et al.. (2006). Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up. Prostate Cancer and Prostatic Diseases. 10(1). 87–93. 22 indexed citations
15.
Sánchez‐Chapado, Manuel, et al.. (2002). Regulation of the expression of protein kinase C isoenzymes in rat ventral prostate: effects of age, castration and flutamide treatment. Life Sciences. 71(19). 2257–2266. 9 indexed citations
16.
Royuela, Mar, et al.. (2001). Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. Journal of Endocrinology. 168(3). 447–454. 129 indexed citations
17.
Arenas, M. Isabel, E Romo, Mar Royuela, et al.. (2001). Morphometric evaluation of the human prostate. International Journal of Andrology. 24(1). 37–47. 16 indexed citations
18.
19.
Royuela, Mar, María P. De Miguel, Fermín Rodríguez de Bethencourt, et al.. (1998). Transforming Growth Factor β and its Receptor Types I and II. Comparison in Human Normal Prostate, Benign Prostatic Hyperplasia, and Prostatic Carcinoma. Growth Factors. 16(2). 101–110. 46 indexed citations
20.
Angulo, J.C., et al.. (1998). One-incision nephroureterectomy endoscopically assisted by transurethral ureteral stripping. Urology. 52(2). 203–207. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P D Abel Breakdown of academic impact, for papers by Hirofumi Koga Breakdown of academic impact, for papers by Markus Müller Breakdown of academic impact, for papers by Janice G. Dodd Breakdown of academic impact, for papers by Shusuke Akamatsu Breakdown of academic impact, for papers by Hitoshi Niikura Breakdown of academic impact, for papers by Paola Muzi Breakdown of academic impact, for papers by Yongmei Chen Breakdown of academic impact, for papers by S. Bruce Malkowicz Breakdown of academic impact, for papers by Vonn Walter
Rankless by CCL
2026